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It has been observed that titers of selected serum proteins 
rise and are elevated during the acute phase of many infectious dis¬ 
eases including those of viral origin (1). Why this occurs however, 
is not known in spite of active research. The best studied of these 
acute-phase reactants is C-reactive protein (CRP). It has been shown 
to interact with the complement system under a number of circumstances. 
This investigation grew from an observation made during the study of 
complement-mediated immune lysis of rubella virus. A serum sample 
with no detectable rubella hemagglutination inhibiting, complement¬ 
fixing or neutralizing antibody, but containing an elevated level of 
C-reactive protein effected lysis of rubella virus. A second serum 
sample from the same patient but collected at a time when CRP was 
not elevated failed to yield significant lysis (2). The present study 
was conceived to test the hypothesis that C-reactive protein as a 
component of the early humoral response to acute viral infaction,acting 
alone or in concert with other serum components such as complement, 
can have a direct lytic effect on enveloped viruses. 
Though much is known of the interaction of antibody and virus, 
less is understood about the interactions of virus and accessory fact¬ 
ors such as the components of complement. Certainly complement acting 
in the presence of antibody has been implicated in humoral defense 
(3-10). Is it unreasonable to suspect that C-reactive protein, long 
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recognlzed as a harbinger of the inf lamina to:.y response, and an evolu- 
tionarily ancient protein (11), may also pr 'Vide some measure of pro¬ 
tection against overwhelming acute viral infection? 
C-reactive protein was purified by affinity chromatography and 
added to purified virus preparations. Evidence for virus-CRP inter¬ 
action was sought by 1) tests for virolysis, 2) complement fixation, 
3) neutralization tests, and 4) electron microscopy. 
II. Literature Review 
The following paragraphs present the early research on C-reactive 
protein in a chronological fashion, discuss the major work delineating 
its biochemical nature and review its biology as a component of the 
inflammatory response. In addition, an effort is made to present 
some data on the mechanisms of complement-effected neutralization and 
virolysis. 
Discovery and Association with Acute-Phase Sera 
In 1930 Tillet & Francis (12) found that serum obtained from 
patients in the acute stage of lobar pneumonia yielded a precipitate 
in the presence of dilute solutions of the ^-polysaccharide of Pneumo¬ 
coccus . 
Precipitins for the C-polysaccharide W2re also found in the sera 
of patients with streptococcal Infection and acute rheumatic fever. 
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Ash (13) extended this observation by demonstrating the precipitation 
reaction in pstients acutely ill with both /:ram positive and gram 
negative infections. In all cases, the precipitation reaction sub¬ 
sided after the cessation of the acute stage. By 1940, Abernethy & 
Avery (14) had conclusively demonstrated that the "acute stage" react¬ 
ant was a protein but not an immunoglobulin and that the presence of 
calcium ions was necessary for C-polysaccharide precipitation. In 
addition, MacLeod & Avery described a method of partial purification 
of the C-reactive protein (15) by ammonium or sodium sulfate precipita¬ 
tion and succeeded in raising rabbit antibody to CRP (16) which did 
not react with normal human or monkey sera but did precipitate human 
or monkey sera from Infected individuals. McCarty succeeded in crystall¬ 
izing the protein from human serous fluids in 1947 (17) and following 
the work of Lofstrom (18, 19), who found acute phase rabbit sera as 
well as human sera caused capsular swelling of certain strains of 
pnetunococcl, Anderson and McCarty crystallized the rabbit acute phase 
protein (20) . The rabbit form was named Cx-reactive protein and was 
found to be remarkably similar to human CRP, 
Biochemical ard Biophysical Characteristics 
Physicocbemical studies by Wood, McCarty and Slater (21) demonstra¬ 
ted that CRP migrates ih the beta-globulin region in moving boundary 
electrophoresis. In contrast, by the method of zone electrophoresis 
on starch medium the protein migrates with the gamma-globulins. Its 
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isoelectric point is at pH 4.82 and its Svec'.berg coefficient is 7.5S. 
Gotschlich and Edelman (22) found GRP crystallized by the method of 
Wood et al. (21) to be an aggregate of probably identidal subunits held 
together by noncovalent interactions. Ultracentrifugation in 5M guani- 
dine-HCl dissociates the protein into subunits with average molecular 
weight 24,300. 8M urea also dissociates the protein to subunits with 
a molecular weight of about 20,000; these subunits give rise to a 
single band in starch gel electrophoresis. They proposed that one of 
several forms of GRP was composed of six identical subunits each with 
an intrachain disulfide linkage and a total molecular weight of 129,000. 
In double immunodiffusion tests with GRP in serum, up to three lines 
of identical specificity have been observed indicating heterogeneity 
of size (23). In response to these observation, Kushner and Sommerville 
(24) determined the molecular weight of GRP as it occurs in serum 
by gel filtration and density gradient centrifugation. They estimated 
that the molecular weight lies between 135,000 and 140,000 consistent 
with a molecule composed of 6 subunits of approximate molecular weight 
23,000. 
Characterization of Receptors for GRP 
Gotschlich and Edelman (25) also studied the CRP-C-polysaccharide 
(CPS) precipitation reaction and found that it could be inhibited by 
phosphate monoesters. Indeed the precipitat.ion inhibition mimicked 
the hapten inhibition phenomenon seen with antigen-antibody reactions. 
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It was suggested that each subunit of CRP could bind one molecule of 
phosphate monoester and that CPS precipitati )n occurred as a lattice 
of interacting molecules formed in a fashion similar to the interaction 
of antibody with polyvalent antigen. Further attempts to characterize 
the specificity of C-reactive protein by Volanakis and Kaplan (26) 
confirmed the inhibition of CRP-CPS precipitation by phosphate mono¬ 
esters but demonstrated that choline phosphate is a markedly more 
active inhibitor of this reaction and thus possibly the major determi¬ 
nant for precipitation of CPS. 
Though these reports present some understanding of the biochemis¬ 
try of C-reactive protein, the literature echoes a common theme. That 
is, that the method of preparation of CRP shapes experimental results 
and at present there is disagreement on the native structure and state 
of CRP vivc. This confusion naturally extends to the biology of 
CRP. Again, differing methods of purification and differing methods 
of measurement with widely varying accuracy and precision, confuse 
the literature and make interpretation a challenge. 
Biological Distribution 
In spite of areas of controversy, it is undisputed that elevated 
levels of C-raactive protein have been found in the blood during 
virtually all diseases associated with active inflammation, particularly 
in patients wi'.th the rheumatoid diseases, acute infectious processes, 
post myocardial infarction or post surgery, advanced malignancy and 
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chronic infections (27-31). Less clear until recently was the incidence 
of measurable GRP during pregnancy, in cord blood, in the newborn and 
in apparently healthy adults. 
CRP has been demonstrated in frequencies as high as 82 per cent 
during the latter part of pregnancy and at parturition, but it was rarely 
found in umbilical cord sera (32, 33). This has been interpreted as 
evidence against transplacental passage of maternal CRP. However, 
more than 50% of newborns in the first week of life showed the presence 
of CRP, many from day one of the newborn period with a rapid decline 
after day four of life (32, 34). Two-thirds of newborns with infection 
had CRP positive sera by the capillary precipitation test (34). 
Methods for Detection and Quantitation 
Before more data on the clinical behavior of CRP are presented, 
the revealing study by Nilsson (35) which evaluated the efficacy of 
quantitative precipitation tests should be reviewed. Nilsson found 
that the capillary tube precipitation test was subject to occasional 
false positive results but more importantly, frequently failed to indi¬ 
cate the presence of CRP detectable by double diffusion in agar. 
However, he regarded neither method as more than semi-quantitative 
and he advanced single radial immunodiffusion as a simple quantita¬ 
tive method a!)le to detect as little as one microgram CRP per milli¬ 
liter. His research casts doubts as to the validity of many of the 
studies done utilizing simple capillary tube precipitation or double 
diffusion to cetect and quantitate CRP. Most recently, Claus et al. (36) 
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in the single definitive study to date, developed a radioimmune 
assay for CRP and then proceeded to demonst rate that CRP is almost 
certainly a constituent of normal human serum which only increases 
substantially in concentration during inflammation. They found, 
by assaying sera from 153 healthy adult blood donors, normal adult 
levels of the protein ranging from 68 to 8,100 ng. per milliliter 
with a median value of 580 ng. per milliliter. No individual was 
found to be lacking CRP. Just as these results contradicted the 
numerous reports that CRP is not present in the sera of healthy adult 
normals, analysis of 24 samples of cord blood found a range of CRP 
concentrations between 10 and 350 ng. per milliliter demonstrating 
that there is indeed either transplacental passage or fetal synthesis 
of this protein. Also, in contrast to the healthy adult levels, CRP 
concentrations in the sera of 246 patients being evaluated for auto¬ 
immune disease ranged from 2,000 ng. per milliliter to 256,000 ng. 
per milliliter with a median of 13,000 ng. per milliliter, a dramatic 
and intriguing increase. This important work substantially revises 
some longstanding conceptions of the as yet undetermined function of 
CRP. 
Time Course oJ' Elevation in Serum Concentration 
Though tne function of C-reactive proucin is not known, more than 
three decades of experimentation have illuminated several aspects of 
its biological behavior. For instance the time course of the rise in 
CRP titer is \rell known. Crockson et al. (37) followed CRP levels pre 
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and post surgery in patients and showed CRP to be detectable within 
24 hours and to reach a peak concentration in one to four days, with 
an average of forty-eight hours. Hokama et al. (38) also found a 
24-hour CxRP^ response in rabbits immunized with intravenous bovine 
serum albumin or human gamma globulin and in addition they noted a 
secondary response which was found to be attributable to the formation 
of intravascular antigen-antibody complexes. The duration of the 
period of net CxRP production and the amount of CxRP formed by rabbits 
in response to the administration of intravenous endotoxin was examined 
in a kinetic study by Yen-Watson and Kushner (39). The CxRP response 
was found to be directly related to endotoxin dose. Serum CxRP con¬ 
centration increased exponentially after endotoxin administration 
with the increases most often noted immediately, although some animals 
had on the average a 6-hour lag time. The data were interpreted as 
suggesting that mediators inducing CxRP synthesis by the liver act in 
an all or none manner, the amount of CxRP formation depending on the 
duration of the mediating stimulus. 
Site of Synthesis 
That the liver is a site of CRP synthesis was nicely worked out 
by Hurliman et al. (40). Monkey and rabbit liver tissue taken from 
animals stimulated with inflammation inducii-.g agents and then incubated 
^CxRP is structurally and functionally analogous to CRP, but 
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in media containing C-lysine and C-isoleucine was found to 
lA 
synthesize C-labeled CRP and CxRP. No other tissue incorporated 
14 
carbon into CRP. There was, in addition, no apparent correlation 
between CRP formation and immunoglobulin production. 
Localization at Sites of Inflammation 
CxRP has also been identified by immunofluorescent staining in 
association with necrosis in the local inflammatory lesions produced 
by intramuscular injection of typhoid vaccine (41). The CxRP was 
detected both in serum and in tissue within eight hours of the inject¬ 
ion and was only found in myofibrils undergoing necrotic change where 
it was localized particularly at the outer edge of these cells and 
in vacuoles in the sarcoplasm. CxRP was not detected in any peri- 
inflammatory tissue, in the polymorphonuclear leukocytes infiltrating 
the lesion or in the cellular elements in the draining lymph nodes. 
The relative number of myofibrils containing CxRP showed progressive 
increase from early lesions at 8 to 12 hours to older lesions at 48 
hours, the end of the period of observation. The identical localiza¬ 
tion of CxRP was seen in animals rendered granulocytopenic by nitrogen 
mustard. Kushner et al. (42) observed identical histochemical localiza 
tion of CxRP in rabbit myocardium rendered necrotic by coronary artery 
ligation. In addition, the protein was fovnd in vascular lumens and 
interstitial spaces. Although these results were not originally 
interpreted as such, they provide reasonable support for the concept 
of localizaticn of circulating CRP at the site of an inflammatory 
response. 
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CRP * s Role as an Opsonin 
Early observations of the capsular swe.''ling effect of CRP on 
the pneumococcus (43) and the ability of CRP, when added to plasma 
above centrifuged normal whole blood, to accelerate the rate at which 
leukocytes leave the huffy layer (44) prompted studies of the effect 
of C-reactive protein on phagocytosis and nonspecific immunity. 
Hokama et al. (45) noted enhancement of phagocytic activity of peri¬ 
pheral blood leukocytes when bacteria were pretreated or mixed with 
CRP prior to the addition of whole blood. This opsonizing effect 
was not seen when the CRP was added directly to heparinized whole 
blood, but subsequent work has shown that this negative result may 
have been due to the binding of CRP by heparin (25). In 1969, Ganrot 
and Kindmark (46) showed that highly purified CRP markedly stimulated 
the phagocytosis of Goffkya tetragena,a nonpathogenic bacterium, by 
human leukocytes and in the following year went on to demonstrate 
the same stimulation of in^ vitro phagocytosis of the human pathogens 
Streptococcus pneumoniae. Staphylococcus aureus, coli, and Klebsiella 
aerogenes (47). Kindmark further strengthened the evidence that CRP 
serves as a bacterial opsonin by demonstrating that pathogenic gram 
positive and gram negative bacteria absorbed C-reactive protein from 
sera taken from postoperative patients and that the protein could 
then be eluted by treatment of the bacteria with EDTA (48). Clearly 
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Complement Consumption and Activation 
Happily, the story does not end here, '‘or in recent years other 
roles for C-reactive protein have been delineated. Kaplan and 
Volanalcis (49) in 1974 demonstrated that the reaction of CRP positive 
sera or crystalline CRP with pneumococcal C-polysaccharide induced 
constimption of human complement and conversion in the absence of 
detectable antibody. All normal human sera tested permitted consumption 
of complement by CRP-CPS complexes, including sera from newborns with 
physiological hypogammaglobulinemia and sera previously adsorbed with 
pneumococcal cell walls to remove trace antibody to C-polysaccharide. 
The complement consumption reaction which consumed 80% or more of 
hemolytic complement C , C., and C , and 42 to 66% of C„-Cq, was 
j. 4 2 j y 
totally inhibited by phosphoryl choline, but not at all by N-acetyl 
galactosamine, the major determinant of CPS antibody specificity. 
CRP also reacted with phosphoryl choline, lecithin and sphingomyelin 
(when these were suspended with cholesterol as a lipid carrier) by 
complement fixation. Immunodiffusion of the washed complexes resulting 
from precipitation of CRP-positive sera with C-polysaccharide or leci¬ 
thin gave strong lines of precipitation against anti-CRP, anti-C and 
antl-C^, whereas immunoglobulins were absent or present only in trace 
quantities. 
Subsequently Siegel et al. (50) found that cationic homopolymers 
of poly-L-lysine were able to activate complement via CRP and deplete 
complement components C-j^ through C^. The n iturally occurring poly¬ 
cations, myelin basic proteins, rabbit leukocyte cationic proteins, 
and lysine and arginine rich histones, were also complement consuming 
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protelns react so with CRP is of special interest, since they accumu¬ 
late at sites of injury and tissue destruction. Siegel speculates 
that this reactivity with CRP results in activation of complement at 
inflammatory sites, and in modulation of the ability of polycations 
to initiate mast cell (51) and platelet (52)activation, or in favoring 
of CRP binding at anionic cell surfaces. These above experiments 
with CRP-mediated complement consumption were studies of complement 
activation in the fluid phase. Osmond et al. (53) made an important 
contribution to this field when they coated erythrocytes with C-poly- 
saccharide and demonstrated that C-reactive protein in reacting with 
them initiated the full biologic expression of complement activation¬ 
cell lysis and death. 
Interaction with the Cellular Elements of Blood 
Contributing to the mounting evidence that C-reactive protein 
is perhaps both a modulator and effector in the inflammatory response 
is the discovery of the interactions between CRP and platelets and 
lymphocytes. Fiedel and Gewurz (54) found that the addition of small 
amounts of CRP (2-25 yg/ml) to an amount of aggregated human IgG 
which induced 50% maximal rate of platelet aggregation significantly 
reduced or abclished this response. Platelet viability remained in¬ 
tact and addi :ion of large amounts of aggregated IgG reversed the 
CRP-induced iihibltion. 
Early studies of the effect of G-reactive protein on lymphocyte 
function were contradictory. Hornung and Fritchi (55) reported that 
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CRP concentrations of 10 micrograms per milliliter were mitogenic, 
whereas twice this concentration of CRP resulted in loss of lympho¬ 
cyte viability and cell death. Hornung later reported that CRP in 
the presence of lymphocytes inhibited the growth of human melanoma 
cells in vitro (56). A conflicting report by Hokama (57) suggested 
that CRP was neither toxic or mitogenic by itself, but it inhibited 
the response to phytohemagglutinin. Additionally, this group found 
that in leprosy patients, CRP in autologous serum may in part be assoc 
3 
iated with the depression of H-thymidine incorporation into the DNA 
of leukocytes (58). 
In an attempt to more systematically examine the effect of CRP 
on lymphocytes, Mortensen and Gewurz (59) found that CRP binds sel¬ 
ectively to T lymphocytes, inhibits their ability to form spontaneous 
rosettes with sheep erythrocytes and inhibits their response to allo¬ 
geneic cells in mixed lymphocyte culture reactions. CRP did not 
bind to B lymphocytes, nor did it alter B cell functions, such as 
binding to activated complement components and to the Fc portion of 
immunoglobulin, or mediating antibody-dependent cytotoxicity reactions 
Furthermore, CRP failed to suppress PHA or concanavalin A-induced 
mitogenesis. Mortensen and Gewurz (60) further defined the effect of 
CRP on the res.ponse to allogeneic cells in a murine system by show¬ 
ing that the CRP binding was to theta bearing, extrathymic T cells, 
and that CRP specifically inhibited the proliferative response. Mur¬ 
ine cytolytic lymphocytes, once generated were not affected by human 
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CRP. It was suggested that suppression of :he mixed lymphocyte 
reaction was due either to a failure to iniciate differentiation of 
cytotoxic lymphocyte precursors or to abrogation of their full dif¬ 
ferentiation. Further unpublished data by rhese workers indicates 
that CRP depresses both the blastogenic response and the elaboration 
of MIF by sensitized human peripheral lymphocytes to antigens. All 
of these data are consistent with the concept that CRP may serve 
some immuno-regulatory function limiting the cellular response during 
inflammation. 
Summary of the Data Supporting CRP*s Role in Defense Against Bacteria 
In summary, the cogent data gleaned from the literature which 
have some bearing on the ”CRP as humoral defense” hypothesis are the 
following: C-reactive protein appears within hours of tissue injury 
and persists for several days. It localizes at sites of injury. It 
can bind to phosphate monoesters and phosphatidyl choline and activate 
complement via the classical pathway. When fixed to red blood cell 
membranes, it can activate complement components Cl through C9 with 
resulting cell lysis. There is evidence to suggest that it fixes to 
and enhances the phagocytosis of various tyues of bacteria. 
CRP and Viral Infections 
It will be noted that there is no ment .on of virological studies 
with C-reactive protein. The field is apparently unexplored with only 
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"found" or elevated during viral infection nuch as it was in bacterial 
infection. T1 ey also mentioned the intrigu..ng preliminary finding 
that partially purified CRP will neutralize the infectivity of polio¬ 
virus types 1 and 3 and will non-specifically fix complement when used 
with a wide variety of viral antigens. This work was not followed 
by later reports extending or confirming these observations. 
Several questions now derive from the preceding two paragraphs; 
Can C-reactive protein bind to a viral envelope? Once bound, can 
CRP mediated complement activation neutralize or lyse the virion? 
It is clear that enveloped viruses acquire their envelopes from 
the cell membrane through which they bud, the lipid and carbohydrate 
produced by the appropriate enzyme system of the host cell, the 
envelope proteins being virion specific (62). It is also clear that 
phosphatidyl choline is a relatively abundant phosphoglyceride in the 
plasma membrane of higher animals (63). If it is postulated that 
CRP can bind to the virion envelope with the subsequent activation 
of complement, what are the possible results? 
The Role of Complement in Virus Neutralization 
The critical role of complement in viral neutralization has al¬ 
ready been intimated in the introduction an 1 a more detailed review 
is now in order. Lennette (64), Svehag (65), Way and Gairwes (3), 
and Chappell et al. (66), have all reported on the ability of a serum 
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accessory factor or a heat labile serum factor to enhance the neutrali¬ 
zation of virvs. In 1968, Berry and Almeidi (67) described the en¬ 
hancement of neutralization of avian infectious bronchitis virus by 
complement (C) as seen with immune electronraicroscopy. Then Daniels 
et al. (5) demonstrated that the sequential addition of the first 
four functionally pure C' components could neutralize sensitized 
virus, offering more support to the hypothesis that C' neutralizes 
by piling up on the virion surface. In these experiments, in the 
presence of an optimal concentration of C^, IgM sensitized herpes 
simplex virus was neutralized by and neutralization was increased 
by the addition of and when the concentration of was limiting. 
Radwan et al. (7-9) in some very neat experiments with sensitized equine 
arteritis virus demonstrated that C’ does not act to stabilize the 
V-Ab complex but that it neutralizes it, most likely in a two step 
reaction, where initially is bound, followed by the late acting 
components and virolysis. Radwan did show that the first four compo¬ 
nents of C’were sufficient to assure complete neutralization of 
sensitized virus in the absence of virolysis. This phenomenon was 
then shown to be true for sensitized polyoma (6) and sensitized Newcastle 
disease virus (68) as well. 
Most rectntly sera with functional C sources were found to in¬ 
activate and lyse avian, feline, murine and simian oncornaviruses 
apparently in the absence of antibody (4). All of these viruses are 
enveloped. Complement seemed to be the mediator of this lysis since 
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agaimnaglobulinemic sera containing less than 10 yg/ml IgG and no 
other Ig was cble to lyse virus while C„ anu C, deficient sera were 
I 4 
not. Subsequent C’ component titrations indicated activation via the 
classical pathway. 
Clearly complement plays an important part in the neutraliza¬ 
tion of virus coated with antibody; there are suggestions that comp¬ 
lement also may act in the absence of antibody. Perhaps in this story 
is a role for CRP. 
Ill. Materials and Methods 
Rubella Virus 
The virus is the Therien wild type rubella virus isolated in 
this laboratory in 1965 (69). It is grown in Vero monkey kidney 
cells in stationary or roller bottles. Details of the cell and virus 
propagation have been described previously by Leibhaber et al. (70). 
The virus was purified in one of two ways. The first method employed 
sucrose gradient centrifugation and has been described by Schluederberg 
et al. (2). Ihe second method precipitated the virus from tissue 
culture fluid utilizing 7% polyethylene glycol (71) and stirring at 
4° C for one to two hours. The precipitate was collected by centri¬ 
fugation at 10,000 rpm, resuspended in a small amount of 0.05M Tris 
buffer containing 0.155M NaCl and layered on a 4 ml gradient cushion 




rotor at 35,000 rpm for three hours and the visible virion band was 
removed through the side of the tube with a syringe and needle and 
stored at -70° C. 
Radioactive Labelling of Rubella Virion RNA 
This procedure has been previously described (2) and is based 
3 
on the addition of 5- H uridine (50 uCi/ml, New England Nuclear Corp.) 
to 72 hour viral cultures thirty minutes after treatment with actino- 
mycin D (5 Pg/ml, Merck, Sharpe, and Dohme) and harvesting virus 
18-24 hours later. 
Influenza Virus 
The influenza virus used for electron microscopy was the Influenza 
A/New Jersey 1976 strain fixed in formaldehyde and suspended in iso¬ 
tonic PBS as a vaccine (Merrell-National Laboratories). 
Neutralization Test (NT) 
The NT was performed with Vero monkey kidney cells grown in 
cluster plates (Costar) of twenty-four 16 mm wells per plate. C- 
reactive protein was added to an equal amount of heated (56°, 30 min¬ 
utes) CRP-negative, NT antibody-negative seviim and two-fold dilutions 
of this were made in PBS containing 2% recor.stituted lyophilized 
guinea pig se'.um (BBL, Division of Becton, Dickinson, and Co.). Each 
serum dilution was mixed with an equal volume of rubella virus suspen¬ 
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incubated overnight at 4° C and for ten minutes at 37° C just prior 
to inoculating 0.1 ml of each serum dilutio i per well in quadruplicate. 
The cultures were put at 37° C, refed with fresh media one hour after 
inoculation and on the fifth day after infection, and were read on 
the eleventh day by checking for hemagglutination in a 1:2 dilution 
of the culture fluid (72). The neutralization titer was expressed 
as the reciprocal of the highest serum dilution which blocked viral 
growth as measured by hemagglutinin production. 
Complement Fixation Test 
The standard microtitration technique employing guinea pig 
complement and 4 units of antigen was used (73). In addition to 
C-polysaccharide, whole rubella virion antigen and soluble rubella 
antigen were employed in tests with CRP. Whole rubella antigen was 
prepared by ammonium sulfate precipitation of several liters of Vero 
monkey kidney cell grown virus. The resulting precipitate was resus¬ 
pended in 0.05M Tris O.IOM NaCl, pH 7.2 and layered on a 15-65% 
(wt/wt) sucrose gradient and centrifuged at 22,500 rpm for 18 hours 
at 4° C. Fractions were collected from the bottom of the tube and 
those fractions comprising the HA peak were pooled and frozen at 
-70° C. Soluble rubella antigen was prepared from the supernatant of 
this centrifugation which was dialyzed against 0.05M Tris O.IOM 
NaCl pH 7.2 for 24-48 hours at 4° and then concentrated three to six 
times with aquacide (Calbiochem). Tween-80 (L. Light and Co., Ltd.) 
was added to a final concentration of 0.125% along with ether to a 
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flnal concentration of 50% and this was continuously stirred for 
30 minutes at 4° C. The mixture was then centrifuged at 3,000 rpm 
for 30 minutes at 4° C and the aqueous phase removed and stirred 
under a stream of nitrogen to remove trace ether. This material was 
also stored at -70° C. 
Pneumoccal C-polysaccharide (CPS) 
This procedure was modified from that of Schiffman et al. (74). 
A Cs-capsulated strain of pneumococcus (kindly provided by Dr. Gerald 
Schiffman, Department of Microbiology and Immunology, State University 
of New York, Downstate Medical Center, Brooklyn, New York) was grown 
overnight in fresh beef heart infusion broth supplemented with 1% 
neopeptone (Difco Laboratories). Glucose was then added to a final 
concentration of 1% and incubation of the culture was continued with 
periodic neutralization with 3N NaOH of the lactic acid formed. At 
the end of the exponential phase of growth, the bacterial cells were 
harvested by centrifugation and allowed to autolyze in 30 ml of 5% 
sodium acetate at 37° C for 18 hours. The insoluble cellular debris 
was removed by centrifugation and the protein was removed by shaking 
with chlorofoinn-butanol (Sevag method), after which procedure the 
aqueous phase was fractionated with ethanol. TTie fraction precipi¬ 
tating between 55 and 75% ethanol was mainly CPS. This was further 
purified by gel filtration on Sephadex G-200 (Pharmacia) in 0.2N 
ammonium acetate. Effluent fractions were assayed by determining 
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their density after lyophilization. Fractions from the resulting 
peak were resuspended, pooled and relyophilLzed. 
C-reactive protein (CRP) 
This method of isolation is slightly modified from that des¬ 
cribed by Osmand et al. (53). Ascites fluid (collected with the kind 
assistance of Dr. Ernest Kohorn, Department of Obstetrics and Gyn¬ 
ecology, Yale University School of Medicine, New Haven, Connecticut) 
from patients with gynecological malignancies was clarified by low 
speed centrifugation and stored at 4° C after the addition of O.OIM 
sodium azide. The affinity chromatography procedure was based on 
the calcium dependent binding of CRP to pneumococcal C-polysaccharide 
(CPS). CPS was coupled to cyanogen bromide activated Sepharose 4B 
(Pharmacia) as described by Wofsy and Burr (75), and 30 ml of gel 
was packed into a small colimin. Clarified ascites fluid (60 ml) was 
washed through the column with 0.05M Tris pH 8.0 with 0.155 M NaCl 
and 2.0 mM CaCl2 until the A^gQ of the effluent was less than 0.020 
and then the CRP was eluted with Tris saline containing 2.0 mM cit¬ 
rate. The resulting fractions were assayed for CRP by immunodiffusion 
against anti CRP (Behring Diagnostics) and the most strongly positive 
were pooled and stored at 4° C until used. 
Quantitation of CRP by Immunodiffusion 
Tests were done on 75 x 25 mm glass slides covered by 2.5 ml of 
gel consisting of 0.4% agarose in O.OIM Tris buffer containing 0.1% 
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sodium azide. Tv70-fold dilutions of CRP containing material were 
made in Tris saline and 20-yl aliquots of these were placed in wells 
5 mm in diameter and 3 mm apart. Results were read after 18 hours 
of incubation in a moist chamber at room temperature. The titer of 
CRP was expressed as the reciprocal of the highest dilution giving a 
visible precipitate. The concentration was expressed in units/yl with 
one unit/yl defined as that dilution giving a sharp precipitate at 
the mid point between the antigen and antibody well. 
Immunoelectrophoresis 
The micro method described by Scheidegger (76) was used. 
Standard Test for Virolysis 
The procedure used was described by Schluederberg et al. (2) 
but was modified by substituting purified CRP for the serum which 
3 
was mixed with equal aliquots of guinea pid complement and 5- H uri¬ 
dine-labelled rubella virus. After overnight incubation at 4° C, an 
aliquot of RNase A (60 yg/ml, Sigma Chemical Co.) was added to the 
test sample and its accompanying controls and these tubes were incu¬ 
bated for two hours at 37° C. After this incubation, the contents of 
each tube were layered on a 2 ml claifying cushion of 20% (wt/wt) 
sucrose. Virions were sedimented through the sucrose layer in an 
sw 51.1 rotor at 40,000 rpm for two hours at 4° C and the radioactivi¬ 
ty of the pellet was measured. 
ilk'ilk ' ' '•* 7\:rafpf.i \s' 
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Measurement of Radioactivity 
Virion pellets were suspended in 400 y1 of solubilizer (NCS) 
(Amersham/Searle) and incubated at room temperature for 30 minutes. 
This was then added to 5 ml of Spectrofluor (Amersham/Searle) and 
counted in a Beclonan model LS-150 scintillation counter to an accuracy 
level of at least 5% after non-radioactive stimulation of fluors had 
fully subsided (1-2 days). When acid-soluble radioactivity was meas¬ 
ured, aliquots of the supernatant from acid precipitation were mixed 
with three volumes of NCS and incubated at room temperature for 30 
minutes before mixing with the scintillation fluid. 
Estimation of Lytic Activity 
CRP and control associated lysis was compared to that effected 
by a standard rubella convalescent serum (MG) which was tested after 
inactivation at 56° C both with heated (negative control) and unheat¬ 
ed (positive control) guinea pig complement. The difference in cpra 
between these two controls was considered to represent 100% efficient 
viroloysis. Thus the difference in cpm bet^/een a given sample's 
pelletable RNA and the negative control's was expressed as per cent 
maximal lysis. 
Preparation of Rubella Virus for Electron Microscopy 
Rubella virus in sucrose stored at -70’ C was rapidly thawed 
and mixed with equal aliquots of CRP, CRP aid guinea pig complement, 
complement or buffer as noted with the expe-imental results. After 
varying incubation periods at 37° C, a drop of the sample was placed 
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on a 300-mesh parlodian and carbon coated grid and left for five min¬ 
utes. The excess fluid was withdrawn with filter paper and the grid 
was turned down on a drop of 2% PTA for 30 minutes. The excess stain 
was then removed and the specimen was ready for examination. 
Preparation of Influenza Virus for Electron Microscopy 
A slight modification of the procedure reported by Edwards et 
al. (77) was utilized. The vaccine virus was diluted 1:4 with 0.05M 
Tris buffer containing 0.155M NaCl, 2.3 mM CaCl2 and 1.0 mM MgCl^ 
or with the reagents to be tested. After incubation for one hour at 
37° C and overnight at 4° C, the samples were pelleted at 15,000 rpm 
for 75 minutes, resuspended in distilled water and negatively stained. 
IV. Results 
Purification of Pneumococcocal E-polysaccharide CCPS) 
Fifteen liters of beef-heart infusion media were seeded with 
75 ml per liter of one day old cultures of Streptococcus pneumoniae 
A,,R-TRIDRS and grown for 24 hours yielding approximately 3.0 grams 
DO 2 55 
of CPS after autolysis and ethanol fractionation. This was placed 
on a sephadex G-200 column, 3.5 x 42 cm, and eluted with 0.2N ammon¬ 
ium acetate. The resulting fractions were concentrated by lyophil- 
ization before testing. The active fractions, comprising a single 
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Preparation of CPS - Sepharose for Affinity Chromatography 
Approximately 2 grams of CPS was disol”ed in 8 ml of O.IM NaHCO^ 
and this was added to 300 ml of the activated sepharose 4B CNBr treat¬ 
ed (76) intermediate. This material was stirred overnight at 4° C 
and then the buffer with uncombined CPS ligand was filtered off. 
Analysis of this wash for the presence of CPS was done by measuring 
its ability to block a CRP immunoprecipitin test. Two-fold dilutions 
were made and each was mixed with an equal amount of C-reactive protein 
positive ascitic fluid.In double diffusion assays, the CPS solution 
employed as a ligand inhibited a CRP-anti CPJ* precipitate to a dilu¬ 
tion of 1:16,000; the wash had no demonstrable CPS activity indicat¬ 
ing all of the CPS had been bound to the sepharose. 
Isolation of C-reactive Protein (CRP) 
Affinity chromatography as described in materials and methods 
and employing small amounts of ascites fluid as a CRP source was 
highly successful. The ascites pool employed had a CRP concentration 
of 4 units/pi and passage through the column removed all demonstrable 
CRP. Elution of the CRP with Tris saline containing citrate eluted 
all CRP within one column bed volume and the resulting CRP peak 
typically had concentrations of 4-8 units/pl. Immunoelectrophoresis 
of the CRP agiinst goat anti-human serum (Fyland Div., Travenol Lab¬ 
oratories, Inc.) failed to show any precipitate while a single line 
was seen agairst anti CRP. This evidence indicated the CRP isolated 
in this fashion was immunologically pure. SDS-acrylamide gel electro- 
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phoresis demonstrated a major band at MW 23,000, the same result ob¬ 
tained by Osmand et al. (53). It should be noted that the CRP thus 
isolated was in citrate buffer and before use, it was necessary to 
add additional calcium to the buffer to a final concentration of 
2.3 mM. Serial determinations of CRP concentration by immunodiffusion 
showed the protein to be antigenically stable for greater than two 
weeks at 4° C. 
Quantitation of C-reactive Protein by Immunodiffusion and Protein 
Determination 
The concentration of one unit of CRP per microliter, as defined 
by immunodiffusion against our standard anti-CRP serum diluted 1:8 
with Tris saline, was found to correspond to a protein concentration 
of 120 yg/ml as measured by the method of Lowry et al. (78). 
Non-Immune Virolysis Mediated by C-reactive Protein 
Because experiments quantitating immune rubella virolysis pro¬ 
vided the genesis for these investigations and because the technique 
as reported by Schluederberg et al. (2) could be modified so that 
purified CRP could be used in place of serum, a number of these 
experiments were performed. However, for unknown reasons there was 
poor reproducibility among experiments as well as a number of experi¬ 
ments in which the virus controls exhibited marked lysis probably 
indicating that the virus employed was damaged. There was only a 
single experiment where the duplicates of each sample matched each 
other and the controls did not invalidate the results. The results 
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are displayed in Table 1. Each sample was approximately equivalent 
in protein coi centration, discrepancies being equalized with BSA pre¬ 
sent at a final concentration of 5%. Each sample had an aliquot of 
either CRP or the buffer in which the GRP was eluted. The BSA was 
dissolved in pH 7.3 veronal buffer containing 0.145M NaCl 0.25mM 
CaCl^ and 8mM MgCl2, so there was sufficient cation concentration to 
permit complement activation even though the concentrations of these 
two ions varied slightly among samples. It should be noted that the 
virus in the negative buffer had 25% lysis as compared to the positive 
control. This was not noted when whole serum (e.g. guinea pig comple¬ 
ment) was present. C-reactive protein induced lysis almost one-half 
as efficiently as antibody in the presence of both active and heated 
complement. It induced no lysis in the absence of guinea pig serum. 
The degree of lysis was significantly more than with the corresponding 
controls (samples 7 and 8). The addition of CPS inhibited CRP-effected 
virolysis. 
It is not likely that this single experiment amidst numerous 
unsuccessful ones is highly significant. It perhaps suggests that CRP 
can mediate virolysis in the presence of one or all of the complement 
components. It is indeed unfortunate that this sensitive technique 
for quantitating virolysis could not be more successfully utilized. 
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Table 1. Lysis of Rubella Virus Following Ircubation in CRP-Containing 
or Control Reaction Mixtures ^ 






Controls: 1 Buffer^ 935 25 
2 Buffer + C’ 1058 12 
3 Buffer + AC* 1254 0 
4 Buffer + C’ + CPS 1125 0 
5 Buffer + C* + immune serum 354 100 
6 Buffer + AC* + immune serum 1130 0 
7 CRP + C* + immune serum 354 100 
Test: 8 CRP 1157 0 
9 CRP + C* 796 43 
10 CRP + AC* 750 49 
11 CRP + C’ + CPS 1048 11 
^Incubation overnight at 4° and 2 hours at 37° in the presence of RNase. 
See materials and methods for details. 
^Samples 5 and 6 defined as 100% and 0° efficiency. 
^Buffer used was a pool of CRP-negative fractic'ns collected in the column 
eluate. Bovine-serum albumin was added to both CRP and buffer cont¬ 
rol to stabilize the virions. 
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Complement Fixation by C-reactive Protein Using \^fhole Rubella Virions 
and Pneumococcal C-polysaccharide as Antige is 
Experiments were set up to see if complement fixation by rubella 
virus and CRP could be demonstrated. To standardize conditions, ini¬ 
tial tests were conducted with CRP and CPS, a combination previously 
shown to fix complement (49, 53). The diluent used was VBD and two 
units of hemolysin (BBL, Division of Becton, Dickenson, & Co.) were 
used. The potency of the CRP preparation was 6 units/yl and two-fold 
dilutions were carried to 1:64. The CRP was found to be consistently 
anticomplementary, indicating that it was binding or inhibiting comple¬ 
ment in the absence of CPS. Further tests were done using a mixture 
of equal aliquots of guinea pig complement and human C as well as 
CRP carried tc higher dilutions in an attempt to diminish its anti¬ 
comp lementarir ess . The mixture of g.p.C* and human C^^ was found to 
have minimal hemolytic activity and this approach was abandoned. 
The anticomplementary activity of the CRP preparation was 
eliminated in subsequent tests in which CRP was diluted in a pool of 
rubella CF-negative serum. Two-fold dilutions of CRP 1:2 in antibody¬ 
negative serum were run against two-fold dilutions of a stock solution 
of CPS in dist.illed water in a checkerboard type pattern to determine 
optimal dilutions of antigen and CRP. For increased sensitivity, 
one unit of guinea pig complement was used in these tests. All 
dilutions of CRP fixed complement using the CPS antigen. One hundred 
per cent or 4-- fixation was observed for CRP dilutions 1:8 through 
■ 
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1:32. This represented approxir.iate CRP concentrations of 600 yg/ml 
through 150 yg/ml. 
Following these positive results, CRP (1:2 in antibody-negative 
serum) diluted 1:4 and 1:16 was tested for complement fixation with 
whole rubella virion antigen as well as with soluble rubella antigen 
and CPS was utilized as a positive control antigen. The results of 
this experiment as well as the previous one are displayed in Table 2. 
The dilutions of the virion and soluble antigens represent four units 
as defined by titration against a standard CF-positive immune serum. 
One unit and 0.5 units of guinea pig complement were used. The 
results here are disappointing. CRP did not fix one unit of comple¬ 
ment with the CPS antigen as it had previously. Why this failed to 
occur is not understood. Additionally, the complement fixation with 
CPS and virion antigen was also seen with an identical dilution (1:4, 
1:8) of negative serum only. 
The conclusions to be drawn are threefold. 1) C-reactive protein 
isolated using the described technique has its anticomplementariness 
reduced by dilution in human serum. 2) CRP has been found to fix comp¬ 
lement in the presence of CPS as previously reported (49, 53). 3) No 
evidence was obtained that CRP has CF activity in the presence of sol¬ 
uble rubella aitigens or whole rubella virion antigen. 
C-reactive Protein Mediated Neutralization of Rubella Virus 
The ability of CRP to neutralize rubellii virus was examined using 
the standard neutralization test performed in this laboratory. CRP 
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Table 2c. Complement Fixation By C-Reactive Protein And 
C-polysaccharide Antigen 
CRP 
1:2 8 16 32 128 256 512 
CPS 1:30 2^ 3 4 4 4 
CPS 1:60 2 3 4 4 4 
CPS 1:120 2 3 4 4 4 
CPS 1:240 2 3 4 4 4 3 3 3 3 
CPS 1:480 2 2 2 2 2 
CPS 1:960 1 1 1 1 1 
CPS 1:1920 + 1 1 1 1 
vBD - - - - - - - - - 
Neg Seriam 
1:2 4 8 16 32 
CPS 1:30 2 - - - - 
CPS 1:240 + - - - 
^Numbers recorded represent degree of fixation on a scale from 0 (-) 
to 4, where - represents complete hemolysis and 4 represents complete 
fixation (no hemolysis). 3 represents nearly complete fixation, with 
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Table 2b. Complement Fixation By C-reactive Protein Using 
C-polysaccharide, l-Zhole Rubella Virion Antigen 
and Rubella Soluble Antigen 
1 Unit C' 0.5 Units C* 
CRP_1:4 1:16 CRP_1:4 1:16 
CPS 1:120 -1 + 2 3 
Vag 1:4 - - 2 3 
Sag 1:8 - - + + 
VBD - - - - 
1 Unit C 0.5 Units C' 
Neg. Serum 1:4 1:16 Neg. Serum 1:4 1:16 
CPS 1:120 + - 4 + 
Vag 1:4 - + 3 3 
Sag 1:8 - - + 
VBD 




was diluted 1:2 in a pool of antibody negative sera from individuals 
who later went on to sero convert with positive rubella HAI titers. 
This resulted in a CRP serum concentration of 240 yg/ml. The five 
samples tested and their neutralization titers are listed in Table 3. 
Sample 3 had sufficient CPS added to it to bind all CRP present. 
Sample 4 had no CRP present, only the buffer in which the CRP was 
eluted. Sample 5 was CRP diluted 1:2 in 0.155M NaCl with 2.3 mM 
CaCl and l.OmM MgCl2 instead of the negative serum. All neutraliza¬ 
tion titers were two or less than two; the slight variation among 
samples is not significant. 
There is no evidence that CRP can neutralize rubella virus in 
vitro under the conditions employed. 
Electron Microscopy of Rubella Virus Incubated with C-reactive Protein 
Rubella virus purified by PEG precipitation followed by sucrose 
gradient centrifugation was suspended in pH 7.4 0.05M Tris with 0.155M 
NaCl. The buffer was also adjusted to have a final bovine serum 
albumin (Sigma Chemical Co.) concentration of 5% as well as being 
2.3 mM CaCl^ and l.OmM MgCl2. This contro], sample of virus plus CRP- 
negative colunn elutant was compared to a test sample, virus incubated 
with CRP having a concentration of 4 unitSy'yl. The incubation period 
was one hour at 37° C. Because the samples were not pelleted, the 
number of virions seen was small. 
The sample of virus control, picture 1, yielded sparse but intact 
virions with discreet borders and regular surface projections, where¬ 
as those virions exposed to CRP, picture 2, had less distinct borders 
with a halo surrounding the individual particles. Such a finding is 
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Table 3. C-Reacti-ve Protein Mediated Neutralization of Rubella Virus 
Sample 
Number 
1 Negative serum 
2 Negative serum & CRP 
3 Negative serum & CRP & CPS 
4 Negative serum & CRP negative buffer 








These samples were tested with a number of post rubella vaccination 
sera which served as positive controls and exhibited positive NT titers. 
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typical of virus coated with antibody (79) and suggests that CRP, the 
same size as IgG and similar to Immunoglobulin in many ways, may 
have coated the virion envelope. 
This experiment was repeated but without diluting the virus in 
Tris saline, so that virus in "negative buffer" was compared to virus 
in CRP-containing buffer. In this case, neither sample had calcium 
ions present thus preculding CRP binding to its recognized substrate. 
Both samples appeared to be identical with mildly hazy and irregular 
borders with definite surface projections. No halos were seen. Though 
both samples indicated that the virus was less well preserved than 
in the initial control preparations examined, the lack of difference 
between samples in the absence of calcium-dependent CRP virion bind¬ 
ing could be iriterpreted as giving support to the hypothesis that the 
differences see.n in the initial experiment were due to CRP-virion 
binding and not due to effects of the CRP buffer. 
Electron Microscopy of Influenza A Virus Incubated with C-reactive 
Protein 
The formaldehyde-fixed influenza A virus was selected for incuba¬ 
tion with CRP because previous microscopy yielded micrographs which 
demonstrated the viral envelope and envelope glycoproteins in good 
detail. It was thought that this virus might provide better insight 
into a possible. CRP-envelope interaction. Picture 3 shows the appear¬ 
ance of the vac'.cine virus diluted with Tris saline. Note its relatively 
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intact appearance with regular surface projections. Picture 4 is of 
the virus incubated with only the buffer in which the CRP was suspend¬ 
ed. It too is relatively intact and appears similar to picture 3, 
the virus control. Picture 5 is of the virus incubated with CRP at 
an approximate concentration of 90 yg/ml. The virus is considerably 
disrupted with negative stain penetrating many more particles than 
in the CRP-negative buffer or the Tris saline controls. The envel¬ 
ope and surface projections appear modified and are certainly less 
distinct. Pictures 6 and 7 are of the virus incubated with an equal 
amount of CRP in the presence of guinea pig complement. In scan¬ 
ning the grid,single virions were quite sparse and several large 
aggregates of virus were noted. These were interpreted as aggre¬ 
gates formed by complement fixed to the virion surface. In addition, 
cellular debris seen in the virus suspension was noted to have membrane 
holes typical of those caused by activated complement. Pictures 8 
and 9 are of the virus incubated with CRP and heated complement and 
the virus plus complement alone. No aggregation or lysis was noted 
in these samples; picture 8 appears quite similar to pictures 3 and 
4, the virus control in Tris saline and the CRP-negative buffer con¬ 
trol. This suggests that heated guinea pig serum confers protection 
on the viral envelope exposed to CRP. 
These photographs suggest that CRP can bind to the influenza 
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V. Discussion 
This study was undertaken to determine the virolytic potential 
of C-reactive protein, an acute phase reactant discovered more than 
forty-five years ago. Though it has been extensively studied, CRT's 
fundamental role as a component of the acute reaction to injury is not 
well understood. There is an intriguing similarity between CRP and 
the immunoglobulins in that they share an ability to mediate many of 
the same in vitro reactions. This as well as the accumulated evid¬ 
ence suggesting that CRP is an important part of the acute antibacter¬ 
ial defense provides a creditable foundation for the CRP mediated 
virolysis hypothesis. The finding of Schluederberg et al. (2) that 
five of nine sera from serologically confirmed rubella susceptibles 
effected rubella virolysis in the presence of guinea pig complement 
almost as completely as a rubella convalescent serum also suggests 
that factors other than antibody can sensitize enveloped virus for 
complement lysis. 
The possibility exists that there are numerous serum factors 
which participate in non-specific neutralization and lysis of virus. 
Because of this, the experiments described were conducted whenever 
possible with purified CRP in a simple Tris saline buffer. The 
affinity chromatography method of CRP purification yielded a pure 
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gel electrophoresis. That the CRP was active was verified by demon¬ 
strating its ability to bind to CPS as well as to fix guinea pig 
complement in the presence of CPS. 
C-reactive protein was initially studied using a system to quant- 
3 
itate virolysis. H-uridine was used to label the rubella virus 
genome and after incubation with CRP and guinea pig complement, ribo- 
nuclease was added in sufficient quantity to degrade the genomes of 
those virions lacking an intact viral envelope. Pelletable radio¬ 
activity represented unlysed virus and thus CRP-complement mediated 
virolysis could be compared to antibody (standard convalescent serum) 
complement induced virolysis. Certain technical considerations were 
found to be important in these experiments. The rubella virus appear¬ 
ed to be exquisitely sensitive to varying ionic and protein environ¬ 
ments. It was necessary to add BSA to the reaction system to stabilize 
the virus in the Tris or veronal buffer. Even this was not entirely 
effective in reproducing the stability achieved with virus incubated 
in human serum, and further attempts to match the pH and cation con¬ 
centration of human serum in the experimental buffer system were not 
sufficient to eliminate the lysis seen in siunples of virus and buffer 
alone. Presumably the 25% lysis seen in the virus plus negative buffer 
control reflec ts the damage to the virion secondary to prolonged 
exposure to temperatures of 4° C or greater. 
The experiment described did not clearly demonstrate that C- 
reactive protein could sensitize the rubella virus for complement 
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lysls. It did indicate that the viral envelope in the presence of 
CRP and a hea : stable constituent(s) of lyophilized guinea pig had 
its integrity compromised, providing ribonuclease with access to 
the virion core. Neither heated or unheated complement alone brought 
about such a change. The addition of CPS prevented this envelope 
alteration, presumably by binding CRP, indicating that CRP was an 
essential reactant. Yet virus incubated with CRP alone manifested 
no envelope permeability change either. Whether the surface effects 
of CRP and complement piling up on the envelope borders changed its 
permeability is not known. Clearly however, the combination of CRP 
and guinea pig serum effected a change in virion structure in this 
particular experiment. 
Because the non-immune virolysis experiments failed to establish 
that C-reactive protein-activated guinea pig complement was responsible 
for the observed virolysis, the ability of the preparation of CRP to 
fix complement was examined. Preliminary to tests employing viral 
substrates, tests were run with the C-polysaccharide as "antigen". 
Repeated trials found CRP diluted in VBD to be anticomplementary, 
binding or inhibiting complement in the absence of CPS. Further tests 
were then carried out using CRP diluted in a pool of CF negative 
serum from rubella susceptibles. This scheme removed all trace anti- 
complementariness. Subsequently, the dilutions of stock CRP and CPS 
necessary for maximal complement fixation were defined. Using the 
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resulting dilution of CPS as a positive conl;rol antigen, and bracket¬ 
ing the ideal CRP dilution, CF tests were done using whole rubella 
virion antigen as well as soluble antigen. The results did not indi¬ 
cate that complement fixation occurred. It; is not clear whether a 
more sensitive assay of complement consumption would have changed 
the findings. 
In another attempt to determine the outcome of CRP-viral envelope 
interaction, the neutralization test was done. CRP was suspended in 
the negative serum pool used previously for CF work and the tests 
were then performed with only slight modification of technique from 
that used routinely to test serum for neutralizing antibodies in 
which complement is present as 2% guinea pig serum. The unequivocally 
negative result with this method seems to indicate that CRP in low 
levels (_< 60 yg/ml) in concert with the guinea pig complement concen¬ 
tration employed in the test is not capable of reducing rubella 
infectivity. 
None of the above methods directly measured envelope-CRP inter¬ 
action per se and electron microscopy was chosen as one remaining 
tool available with this potential. This technique is a sensitive one 
in studying vdrolysis (80) and it requires ?nly minimal handling of 
virus. 
The results of microscopy work done with rubella seem clear in 
two aspects. First, it is apparent that CR’ has some disruptive 
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effect on the virion envelope. Secondly, this effect seems to occur 
as a result of actual CRP-envelope binding as indicated by the halos 
seen around CRP incubated virions. Future work was done with form¬ 
aldehyde fixed influenza A virus because of increasing problems of 
instability of purified rubella virus preparations. 
The results of work done with influenza virus also suggest that 
CRP has a direct effect on the virion envelope leading to disruption 
or a change in permeability that permits the entry of negative stain 
to the virion interior. The addition of unheated guinea pig serum 
to virus incubated with CRP led to agglutination of virions. In 
addition, typical C’-induced membrane holes were seen in virions and 
in cell debris coincidently suspended in the influenza vaccine. Pre¬ 
sumably, these cell membranes as well as the viral envelopes had been 
modified by the incorporation of virus-specified proteins. Comple¬ 
ment alone did not induce these changes. Activation of complement 
with subsequent virolytic activity appeared to be mediated by CRP. A 
puzzling observation was the apparent protection conferred on influ¬ 
enza virus exposed to CRP by heated guinea pig serum. Virus incubat¬ 
ed with CRP alone appeared to have envelope damage. Where virus was 
incubated with CRP in the presence of heated guinea pig serum, this 
was not seen. The mechanism or significance of this phenomenon is 
not known nor was this noted in the rubella virolysis experiments. 
The dramatic agglutination of influenza virions by CRP and guinea 
pig serum was unexpected, as agglutination is not a usual consequence 
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of guinea pig complement fixation. It is unfortunate that there was 
insufficient time to confirm or extend these preliminary findings. 
It would be desirable, for example, to attempt to repeat these observa¬ 
tions using viable unfixed influenza virions. 
This work provided preliminary evidence that C-reactive protein 
at concentrations seen in acute-phase human serum can interact with 
the envelope of rubella and formalin-fixed influenza virus ^ vitro 
to change membrane meability or configuration. Interaction with 
serum proteins may ensue which can lead to agglutination or to viro- 
lysis. The significance of these findings is unclear, although there 
is reason to suspect that CRP instigated phenomena may apply to all 
enveloped viruses. It should be noted that CRP and complement are 
present in extracellular fluid, where they presumably are able to 
Interact with virus released from host cells: or budding through host 
cell membranes. They are also able to interact with the virus during 
viremia. In addition, the possibility of CRP-complement interaction 
with cells bearing viral antigens has been raised. Perhaps CRP plays 
a very direct role in host defense against viral disease in the days 
following infection but before an immune response has been mounted. 
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Picture 1 (above) is a rubella virion negatively stained after 
incubation in CRP-negative column elutant. Its well demarcated 
border and discreet surface projections are easily seen. 
Picture 2 (below) is a negatively stained rubella virion from 
the sample incubated in CRP. Though the virion core seems intact, 
the envelope border is not discreet and there appears to be a halo 






Picture 3 is a negatively stained preparation of formalin-fixed 
influenza A virus suspended with Tris saline. These virions are 
intact with the regular envelope glycoprotein projections character¬ 




Picture 4 is a negatively stained preparation of the formalin 
fixed influenza A virus incubated with only the buffer in which the 
CRP was suspended. These particles are relatively intact and appear 









Picture 5 is a negatively stained preparation of the influenza 
A virus which has been incubated with CRP. The virions appear con¬ 
siderably disrupted with negative stain penetrating to the core of 
many of the particles. The envelope and surface projections appear 
modified and are less distinct than those seen in the virus control. 





Picture 6 is a negatively stained preparation of the influenza 
A virus incubated with both CRP and guinea pig complement. Large 
aggregates of virions such as the one above were seen; single virions 
were quite sparse. Many of the particles in this aggregate have 
stain which has completely penetrated the interior indicating the 




Picture 7 is a negatively stained preparation of the influenza A 
virus incubated with CRP and guinea pig complement. Most of the 
particles in this micrograph are pieces of cell debris coincidently 
suspended along with the virus in the vaccine preparation. Note the 
many complement mediated membrane lesions seen as small dark holes. 





Picture 8 is a negatively stained preparation of the influenza 
A virus incubated with CRP and guinea pig complement heated at 56° C 
for 30 minutes. These particles are intact and strongly resemble 






Picture 9 is a negatively stained preparation of the influenza 
virus incubated in guinea pig complement (guinea pig serum) alone. 
The particles also appear intact and resemble the virus control part¬ 
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